TY - JOUR
T1 - Dynamic pathology for circulating free DNA in a dextran sodium sulfate colitis mouse model
AU - Koike, Yuhki
AU - Uchida, Keiichi
AU - Tanaka, Koji
AU - Ide, Shozo
AU - Otake, Kohei
AU - Okita, Yoshiki
AU - Inoue, Mikihiro
AU - Araki, Toshimitsu
AU - Mizoguchi, Akira
AU - Kusunoki, Masato
N1 - Funding Information:
This work was partly supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (KAKENHI 25462771 to Y. K.). No additional external funding was received for this study.
Publisher Copyright:
© 2014, Springer-Verlag Berlin Heidelberg.
PY - 2014/11/13
Y1 - 2014/11/13
N2 - Purpose: In sepsis, circulating free DNA (cf-DNA) is increased, and is a marker of severity and prognosis of septic patients. This study aimed to evaluate cf-DNA in a dextran sodium sulfate-induced colitis mouse model, and its clinical implications.Methods: Dynamic pathology of the cecum wall in the DSS-induced colitis mouse model was analyzed using multiphoton microscopy (MPM). Plasma cf-DNA concentrations in colitis mouse were quantified using PicoGreen dsDNA Assay Kit. Plasma cf-DNA was also measured in 123 human ulcerative colitis (UC) patients [mean age: 35.9 years (3–75 years) with 20 pediatric patients] to assess its relationships with clinical severity and Matt’s grade.Results: Real-time images of cf-DNA were detected in the colitis model. The amount of labeled cf-DNA in the circulation of the colitis mice group was significantly higher compared with that in the control group (P < 0.05). In human UC blood samples, plasma cf-DNA concentrations in UC patients were significantly positively correlated with the clinical severity of UC and Matt’s grade (P < 0.05, P < 0.05, respectively).Conclusions: Using MPM, we observed and analyzed real-time images of cf-DNA in a colitis mouse model. Plasma cf-DNA is a potential non-invasive blood marker for reflecting clinical severity and mucosal damage in UC patients.
AB - Purpose: In sepsis, circulating free DNA (cf-DNA) is increased, and is a marker of severity and prognosis of septic patients. This study aimed to evaluate cf-DNA in a dextran sodium sulfate-induced colitis mouse model, and its clinical implications.Methods: Dynamic pathology of the cecum wall in the DSS-induced colitis mouse model was analyzed using multiphoton microscopy (MPM). Plasma cf-DNA concentrations in colitis mouse were quantified using PicoGreen dsDNA Assay Kit. Plasma cf-DNA was also measured in 123 human ulcerative colitis (UC) patients [mean age: 35.9 years (3–75 years) with 20 pediatric patients] to assess its relationships with clinical severity and Matt’s grade.Results: Real-time images of cf-DNA were detected in the colitis model. The amount of labeled cf-DNA in the circulation of the colitis mice group was significantly higher compared with that in the control group (P < 0.05). In human UC blood samples, plasma cf-DNA concentrations in UC patients were significantly positively correlated with the clinical severity of UC and Matt’s grade (P < 0.05, P < 0.05, respectively).Conclusions: Using MPM, we observed and analyzed real-time images of cf-DNA in a colitis mouse model. Plasma cf-DNA is a potential non-invasive blood marker for reflecting clinical severity and mucosal damage in UC patients.
UR - http://www.scopus.com/inward/record.url?scp=84922004437&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84922004437&partnerID=8YFLogxK
U2 - 10.1007/s00383-014-3607-6
DO - 10.1007/s00383-014-3607-6
M3 - Article
C2 - 25367095
AN - SCOPUS:84922004437
SN - 0179-0358
VL - 30
SP - 1199
EP - 1206
JO - Pediatric Surgery International
JF - Pediatric Surgery International
IS - 12
ER -